메뉴 건너뛰기




Volumn 10, Issue 3, 2013, Pages 285-287

Improving adherence to injectable disease-modifying drugs in multiple sclerosis

Author keywords

Adherence; Autoinjector; Interferon beta; Multiple sclerosis

Indexed keywords

BETA INTERFERON; FINGOLIMOD; FUMARIC ACID DIMETHYL ESTER; GLATIRAMER; TERIFLUNOMIDE;

EID: 84873902846     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.763793     Document Type: Review
Times cited : (36)

References (12)
  • 2
    • 84868687150 scopus 로고    scopus 로고
    • Self-reported adherence with the use of a device in a clinical trial as validated by electronic monitors: The VIBES study
    • Jeffrey BA, Hannan MT, Quinn EK, et al. Self-reported adherence with the use of a device in a clinical trial as validated by electronic monitors: the VIBES study. BMC Med Res Methodol 2012;12:171
    • (2012) BMC Med Res Methodol , vol.12 , pp. 171
    • Jeffrey, B.A.1    Hannan, M.T.2    Quinn, E.K.3
  • 4
    • 84872739719 scopus 로고    scopus 로고
    • RebiSmart (version 1.5) device for multiple sclerosis treatment delivery and adherence
    • Lugaresi A. RebiSmart (version 1.5) device for multiple sclerosis treatment delivery and adherence. Expert Opin Drug Deliv 2013;10(2):273-83
    • (2013) Expert Opin Drug Deliv , vol.10 , Issue.2 , pp. 273-283
    • Lugaresi, A.1
  • 5
    • 79959846501 scopus 로고    scopus 로고
    • Supportive strategies to improve adherence to IFN beta-1b in multiple sclerosis-results of the betaPlus observational cohort study
    • Pozzilli C, Schweikert B, Ecari U, Oentrich W. Supportive strategies to improve adherence to IFN beta-1b in multiple sclerosis-results of the betaPlus observational cohort study. J Neurol Sci 2011;307:120-6
    • (2011) J Neurol Sci , vol.307 , pp. 120-126
    • Pozzilli, C.1    Schweikert, B.2    Ecari, U.3    Oentrich, W.4
  • 6
    • 0032796185 scopus 로고    scopus 로고
    • Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice
    • DOI 10.1016/S0149-2918(99)80026-5
    • Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999;21:1074-90; discussion 1073 (Pubitemid 29326165)
    • (1999) Clinical Therapeutics , vol.21 , Issue.6 , pp. 1074-1090
    • Farmer, K.C.1
  • 7
    • 52449117935 scopus 로고    scopus 로고
    • Steigerung der Therapietreue durch ein Therapiebegleitprogramm bei Multipler Sklerose
    • Ries S, Elias WG, Japp G, Lang M. Steigerung der Therapietreue durch ein Therapiebegleitprogramm bei Multipler Sklerose. Nervenheilkunde 2008;28:818-22
    • (2008) Nervenheilkunde , vol.28 , pp. 818-822
    • Ries, S.1    Elias, W.G.2    Japp, G.3    Lang, M.4
  • 8
    • 65749088247 scopus 로고    scopus 로고
    • Factors that influence adherence with disease-modifying therapy in MS
    • Treadaway K, Cutter G, Salter A, et al. Factors that influence adherence with disease-modifying therapy in MS. J Neurol 2009;256:568-76
    • (2009) J Neurol , vol.256 , pp. 568-576
    • Treadaway, K.1    Cutter, G.2    Salter, A.3
  • 9
    • 84855895068 scopus 로고    scopus 로고
    • Adherence to medications: Insights arising from studies on the unreliable link between prescribed and actual drug dosing histories
    • Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol 2012;52:275-301
    • (2012) Annu Rev Pharmacol Toxicol , vol.52 , pp. 275-301
    • Blaschke, T.F.1    Osterberg, L.2    Vrijens, B.3    Urquhart, J.4
  • 10
    • 84865973828 scopus 로고    scopus 로고
    • Cognitive dysfunction in multiple sclerosis
    • Guimaraes J, Sa MJ. Cognitive dysfunction in multiple sclerosis. Front Neurol 2012;3:74
    • (2012) Front Neurol , vol.3 , pp. 74
    • Guimaraes, J.1    Sa, M.J.2
  • 11
    • 78751636602 scopus 로고    scopus 로고
    • Long-term follow-up of clinical trials of multiple sclerosis therapies
    • Freedman MS. Long-term follow-up of clinical trials of multiple sclerosis therapies. Neurology 2011;76:S26-34
    • (2011) Neurology , vol.76
    • Freedman, M.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.